Skip to main content
Download PDF

β-Glucan from Lentinula edodes prevents cognitive impairments in high-fat diet-induced obese mice: involvement of colon-brain axis

Journal of Translational Medicine volume 19, Article number: 54 (2021) Cite this article

Abstract

Background

Long-term high fat (HF) diet intake can cause neuroinflammation and cognitive decline through the gut-brain axis. (1, 3)/(1, 6)-β-glucan, an edible polysaccharide isolated from medical mushroom, Lentinula edodes (L. edodes), has the potential to remodel gut microbiota. However, the effects of L. edodes derived β-glucan against HF diet-induced neuroinflammation and cognitive decline remain unknown. This study aimed to evaluate the neuroprotective effect and mechanism of dietary L edodes β-glucan supplementation against the obesity-associated cognitive decline in mice fed by a HF diet.

Methods

C57BL/6J male mice were fed with either a lab chow (LC), HF or HF with L. edodes β-glucan supplementation diets for 7 days (short-term) or 15 weeks (long-term). Cognitive behavior was examined; blood, cecum content, colon and brain were collected to evaluate metabolic parameters, endotoxin, gut microbiota, colon, and brain pathology.

Results

We reported that short-term and long-term L. edodes β-glucan supplementation prevented the gut microbial composition shift induced by the HF diet. Long-term L. edodes β-glucan supplementation prevented the HF diet-induced recognition memory impairment assessed by behavioral tests (the temporal order memory, novel object recognition and Y-maze tests). In the prefrontal cortex and hippocampus, the β-glucan supplementation ameliorated the alteration of synaptic ultrastructure, neuroinflammation and brain-derived neurotrophic factor (BDNF) deficits induced by HF diet. Furthermore, the β-glucan supplementation increased the mucosal thickness, upregulated the expression of tight junction protein occludin, decreased the plasma LPS level, and inhibited the proinflammatory macrophage accumulation in the colon of mice fed by HF diet.

Conclusions

This study revealed that L. edodes β-glucan prevents cognitive impairments induced by the HF diet, which may occur via colon-brain axis improvement. The finding suggested that dietary L. edodes β-glucan supplementation may be an effective nutritional strategy to prevent obesity-associated cognitive decline.

Background

Obesity prevalence is increasing steadily around the world that has a devastating impact on the sustainable health of individuals in the long-term [1]. Obesity is not only associated with insulin resistance, type 2 diabetes mellitus, cardiovascular disease and steatohepatitis, but can also increases the risk of developing neurodegenerative diseases such as Alzheimer’s disease (AD) [2, 3]. Evidence shows that obesity and/or high fat feeding are associated with deficits in learning, memory, and executive functioning [4, 5] and potentially brain atrophy [6]. However, effective therapeutic manipulation still lacks. Thus, it is urgent to clarify the underlying mechanism of obesity-induced cognitive decline and develop a targeted therapeutic strategy.

Neuroinflammation is proposed to be an important pathophysiological hallmark underlying cognitive decline [7]. Microglia, being the resident immune cells of the central nervous system, plays an important role in maintaining brain homeostasis and contributes towards brain development under normal conditions. However, excessive microglial activation can mediate cognitive impairment via inducing progressive loss of neurons [8]. Hence, addressing neuroinflammation mediated by microglia bears great promise as a novel treatment strategy to reduce neuronal damage and to foster a permissive environment for further regeneration effort [9].

Gut microbiota can affect brain plasticity and cognitive function through the gut-brain axis. The gut microbiota maintains host intestinal homeostasis and regulates immunity. It is reported that Bacteroides fragilis of Bacteriodetes phylum can increase tight junction proteins expression and attenuate intestinal permeability, while Ruminococcus of Firmicutes phylum can degrade mucus [10]. In the mice fed by a long-term high-fat (HF) diet, an increase in intestinal permeability allows the translocation of bacteria or bacterial lipopolysaccharide (LPS) into the blood circulation and then induces systemic inflammation. Moreover, these cytokines can infiltrate in the brain via the blood–brain barrier and act on microglia to induce local production of proinflammatory cytokines, thereby triggering neuroinflammation and cognitive impairment. Furthermore, evidence from germ-free, antibiotic-treated and pathogen-free rodents has revealed gut microbiota dysbiosis negatively affect hippocampal neurogenesis and brain development via microglia activation [11, 12], suggesting a vital role of gut microbiota in cognitive function. Therefore, the gut-brain axis is considered as the potential therapeutic target for HF induced neuroinflammation and cognitive decline [13,14,15,16].

Lentinula edodes (L. edodes) is one of the most popular edible mushrooms in the global market, and (1, 3)/(1, 6)-β-glucan is its major bioactive component. The biological activities of the β-glucan have attracted more attention recently in the medical fields not only due to its nutritional value but also to the possible potential for therapeutic applications [17]. It has been reported that L. edodes can be used medicinally for diseases involving hyperlipidemia, hypertension and diabetes [17]. Interestingly, two studies have reported that the supplementation of L. edodes derived β-glucan for consecutive 28 days can improve gut microbiome dysbiosis in aged mice [18], and thereby improve insulin resistance in insulin-deficient type 2 diabetic rats [19]. Moreover, a recent cross-sectional study has shown that mushroom consumption had reduced the incidence rate of mild cognitive impairment in aged individuals in Singapore [20]. These findings suggest that the main ingredient of L. edodes, β-glucan, may have the potential to regulate gut microbiota and gut-brain axis. However, it is unknown if L. edodes derived β-glucan can prevent microbiota dysbiosis induced by HF diet and thereby improve cognitive impairments via gut-brain axis.

In this study, we designed short-term and long-term experiments of L. edodes derived β-glucan supplementation to examine acute effects on gut microbiota and chronic effects on cognition and its underlying gut-brain axis. The composition of gut microbiota was examined in a short-term experiment for 7 days prior to body weight alteration. Most research of gut microbiota studies in humans and rodents are chronic studies. For example, studies have shown that chronic HF diet induced microbial dysbiosis with regards to the diversity and composition [15, 21]. However, the study of gut microbiota after an acute HF diet and intervention is rare. The results of short-term experiment indicate that L. edodes derived β-glucan supplementation prevented the microbial dysbiosis which appears in the early stage of HF diet feeding, before the onset of significant weight gain and obesity. Furthermore, a similar gut microbiota composition was observed after long-term supplementation of the β-glucan. The chronic high fat diet-fed mice are a commonly used animal model of cognitive impairment reported in the literature. In the long-term experiment, we assessed the effects of dietary L. edodes β-glucan supplementation by measuring behavioral tests, synaptic ultrastructure, neuroinflammation and brain-derived neurotrophic factor (BDNF) expression in the critical brain region, prefrontal cortex and hippocampus. Moreover, the intestinal parameters, including the colonic mucus thickness and tight junction protein expression, as well as serum endotoxin (LPS) level, were also evaluated. We demonstrated that chronic L. edodes derived β-glucan supplementation prevented HF diet-induced cognitive deficits with improvement in the gut-brain axis.

Materials and methods

Animals and treatment

Sixty C57Bl/6J male mice (9 weeks old) were purchased from the Experimental Animal Center of Xuzhou Medical University (Xuzhou, China, SCXK (Su) 2015–0009), and all mice were housed in SPF conditions (temperature 22 °C, 12 h light/dark cycle) and given free access to standard food and water. The mice were acclimatized for 7 days before the experiment and were randomly divided into two experiments: short-term experiment and long-term experiment (N = 30 per experiment). For each experiment, mice were further assigned to three groups (N = 10 per group): (I) Mice were fed a lab chow (LC) diet (5% fat by weight) as a control (LC) group. The LC diet (lab autoclavable rodent diet for maintenance, Beijing Keao Xieli Feed Co., LTD) is grain-based including, ground corn, dehulled soybean meal, fish powder, ground wheat, brewers dried yeast, soybean oil, salt, multivitamin and minerals et al.; (II) Mice received the HF diet (30% fat by weight) as the HF group. HF diet was made from semi-synthetic materials according to the recommendation of “AIN93 Diet for Laboratory Rodents”. The detailed composition contains lard 260 g, soybean oil 55 g, cornstarch 193 g, sucrose 192 g, gelatine 50 g, casein 130 g, methionine 3 g, cellulose 51 g, minerals 50 g and vitamins 13 g; and (III) Mice were fed the HF diet supplemented with the β-glucan from L. edodes (500 mg/Kg food, β-glucan at the dose of ~ 1.5 mg per mouse/day, ~ 60 mg /Kg body weight) [22, 23] as the HFL group. The β-glucan from L. edodes (≥ 98%, Yuanye Biotechnology Co., Ltd, Shanghai, China) was added and mixed into the HF diet. For the short-term experiment, mice received the respective diets for 7 days. Body weight and food intake were recorded every day. Mice were then euthanized, their cecal contents were collected and stored at − 80 °C for further analyses. For long-term experiments, mice were administered the three diets for 15 weeks. Body weight and food intake were measured on the last day of each week. The cognitive behaviour tests were performed (N = 10 per group), including the temporal order memory test, the novel object recognition test and the Y-maze test. Mice were sacrificed 4 days after behavioural testing with CO2. Liver and fat pads (subcutaneous, epididymal and brown) were dissected and weighed. Blood serum, intestinal, liver and brain tissues were also collected and stored in − 80 °C for further analyses. All mice in the experiment were fed ad libitum. All animal care and experiments were approved and carried out according to the ethics committee of Xuzhou Medical University.

Behavioral testing

The temporal order memory test was performed based on methods previously described [15]. Briefly, the experiment comprised two sample trials and one test trial with an inter-trial interval of 60 min between each trial. Place mice in behavioral testing room 1 h before the test so they can acclimatize to the conditions. In each sample trial, the mice were allowed to explore two copies of the same object for 4 min; the objects were different between the two sample trials (sample trial 1: object A and A’; sample trial 2: object B and B’). During the test trial, one object from sample trial 1 (A; old familiar) and another object from sample trial 2 (B; recent familiar) were presented parallel and mice were allowed to explore the open field undisturbed for 3 min. A discrimination ratio was calculated by using the formula [(old familiar time − recent familiar time)/total exploration time]. Intact object recognition memory for temporal order was considered if the mice spent more time exploring the old familiar object compared with the recent familiar object.

The novel object recognition test (ORT) was performed based on methods previously described [24]. Briefly, there are three stages in the ORT. The first stage is habituation, in which a mouse is allowed to explore the open field for 5 min. After 24 h, beginning the training stage, in which the mouse allowed to explore the arena for 5 min with 2 identical objects placed parallel. After 1 h, retention session takes place. Mice are allowed to explore the arena with one of the familiar objects and one novel object placed parallel for 5 min. The discrimination index was evaluated by using the formula [Time with recent object/(Time with the older object + Time with recent object)] × 100.

The Y-maze test was performed based on methods previously described [25]. After acclimatization of the mice, label the arms of the maze with different pictures. Put the mouse in the center and allow to explore the maze undisturbed for 8 min. Record the number of all arm entries and alternations. An alternation is defined as the mouse entering all three arms consecutively. The alternation triplet (%) was calculated as [number of successful alternations/(total number of arms entries-2) × 100].

Intraperitoneal glucose tolerance test (GTT)

Glucose tolerance test was performed 3 days after behavioral testing. After fasting for 16 h, mice were given a glucose solution in the abdominal cavity at a dose of 2 g/kg. The tail-tip blood samples were collected at 0, 30, 60, 90, and 120 min after injection, and a glucose monitor was used to detect the concentration of blood glucose. The curve of blood glucose over time was drawn by Graphpad 8 software and the total area under the curve (AUC) was calculated.

Transmission electron microscopy (TEM)

After transcardial perfusion with saline, brain tissues were taken out and 1 mm3 of tissue blocks from the cornus ammonis (CA1), CA3 and dentate gyrus (DG) regions of the hippocampus and prefrontal cortex were dissected. Samples were fixed in a 2% paraformaldehyde-2.5% glutaraldehyde mixture for 24 h and treated post-fixation with 1% osmium tetroxide (OsO4) for 2 h, before dehydration in an ascending graded ethanol series and embedding in epoxy resin. Sections (70 nm) were cut and stained with 4% uranyl acetate and 0.5% lead citrate. Ultrastructure of synapses was measured under a transmission electron microscope (FEI, Portland, USA), and synaptic morphometrics were studied. Three indexes (Postsynaptic density, synaptic clefts width and the curvature of the synaptic interface) were compared using Image J software as described previously [26].

LPS determination

LPS levels in sera were detected using a chromogenic end-point TAL kit (Xiamen Bioendo Technology Co., Ltd, Xiamen, China) according to the manufacturer’s protocol. The absorbance was determined at a wavelength of 545 nm using a spectrophotometer (Asuragen ClinBio128, USA). All samples for LPS measurements were performed in duplicate.

Cecal content collection

Fresh cecal contents of mice after short-term and long-term experiments were collected into individual sterile EP tubes, quickly frozen in liquid nitrogen, and then transferred into an – 80 ℃ cryogenic freezer until DNA extraction for microbiota analysis by 16S rRNA gene sequencing.

Gut microbiota analysis

Genomic DNA amplification, operational taxonomic units (OTUs) and sequencing were conducted as previously reported [14, 15]. Briefly, the DNA from cecal contents in short-term and long-term experiments were extracted following the instruction of HiPure stool DNA kit (Magen, Beijing, China). The 16S rDNA V3-V4 region of the Eukaryotic ribosomal RNA gene were amplified by PCR using primers 341F: CCTACGGGNGGCWGCAG; 806R: GGACTACHVGGGTATCTAAT, where the barcode is an eight-base sequence unique to each sample using the MiSeq Illumina 2500 platform (Shanghai Majorbio Biopharm Technology Co., Ltd., Shanghai, China) following the standard protocols. The 16S rRNA sequencing data set generated by MiSeq operation was merged and decomposed into each sample using the QIIME version 1.9.0. OTUs were clustered with 97% similarity cutoff using UPARSE (version 7.1 http://drive5.com/uparse/), and chimeric sequences were identified and removed using UCHIME. The taxonomy of each 16S rRNA gene sequence was analyzed by RDP Classifier (http://rdp.cme.msu.edu/) against the silva (SSU115)16S rRNA database using confidence threshold of 70%. OTUs with number less than 0.005% of the total sequence number were excluded. The linear discriminant analysis (LDA) effect size (LEfSe) was used to detect the features of gut microbiota with significant difference abundances between designated taxa with the Kruskal−Wallis rank-sum test.

Histological staining and immunohistochemistry

All animals were killed using CO2 asphyxiation followed by cervical dislocation. The gastrointestinal tracts were quickly removed. The colons were gently separated, by cutting at the cecum-colon junction and the rectum, and immediately preserved in Carnoy’s fixative (fresh anhydrous methanol:chloroform:glacial acetic acid in the ratio 60:30:10). The descending colons were fixed in Carnoy’s solution (twice for 3 h). The colons were then washed in anhydrous methanol for 2 h, placed in cassettes and stored in anhydrous methanol at 4 ℃ for further use. For the detection of colonic mucus layer thickness, post Carnoy’s fixation, methanol-stored colon samples were embedded in paraffin, cut into thin Section (5 μm), and mounted on glass slides with Alcian blue staining as previously described [27], and the thickness of colonic mucus layer was measured using Image J.

The immunohistochemical staining has been described in our previous study [15]. Briefly, fixed colon tissues were embedded in paraffin and sectioned at 5 μm. The sections were rehydrated in xylene and then in graded ethanol solutions. The sections were then washed in 3% H2O2 in methanol for 30 min. For brain tissues, fixed tissues were sectioned at 20 μm, using phosphate buffer saline (PBS) washed 3 times for 10 min, and then washed in 1% H2O2 in PBS for 30 min. All sections were blocked with 5% normal goat serum and incubated with indicated primary antibodies at 4 °C overnight. Primary antibodies were anti-F4/80 (ab16911, Abcam, UK, 1: 1000 dilution) for the colon and anti-Iba1 (019-19741, Wako Pure Chemical Industries, Japan, 1: 1000 dilution) for the brain. Following primary antibody incubation, sections were washed with PBS and then incubated with goat anti-rabbit IgG H&L (ab6702, Abcam, UK, 1: 500 dilution) at 37 °C for 2 h. Finally, using the DAB peroxidase substrate kit (Cell Signaling Technology, Boston, USA) to wash the sections and the sections were counterstained with hematoxylin (Sigma-Aldrich, St. Louis, USA). Six fields from three sections of each mouse were viewed by OLYMPUS IX51 microscope (Tokyo, Japan) and digital photographs were captured. Image J software was used to quantify the cells of F4/80 and Iba1 immunoreactivity on each field. The immunohistochemical staining F4/80 and Iba1 were quantified as a percentage of positive cells on each field.

Western blotting

Western blot assay was performed as described previously [28]. Briefly, proteins were extracted from tissues of the colon, hippocampus and prefrontal cortex in cell lysis buffer containing RIPA buffer (Sigma-Aldrich, St. Louis, USA), Protease Inhibitor Cocktail (Sigma-Aldrich, St. Louis, USA) and 1 mM PMSF (Sigma-Aldrich, St. Louis, USA), and then quantified by BCA assay (Beyotime Biotech, Beijing, China). 20–40 μg of protein, was separated by electrophoresis in 10% SDS-PAGE and separated proteins were transferred to polyvinylidene difluoride (PVDF) membranes with a Bio-Rad electrophoresis system (Hercules, CA, USA). The membranes were blocked with 5% skim milk powder and then incubated overnight at 4 °C with different primary antibodies diluent (Occludin, ab167161, Abcam, UK, 1: 2000 dilution; BDNF, ANT-010, Alomone Labs, Israel, 1:200 dilution; PSD-95, #3450, Cell Signaling Technology, Boston, USA, 1: 1000 dilution; GAPDH, A2077, ABclonal Biotechnology Co., Ltd, USA, 1:2000 dilution). The membranes were then washed three times for 10 min and incubated with the anti-rabbit IgG conjugated with horseradish peroxidase (sc-2030, Santa Cruz Biotechnology, USA, 1:2000 dilution)) for 1 h at room temperature. Immunodetection was performed using Clarity™ ECL western blot substrate (Bio-Rad, USA) and visualized with the ChemiDoc Touch imaging system (Bio-Rad, USA). The expression of protein in each sample was normalized to GAPDH.

RNA extraction and quantitative real-time PCR (RT-qPCR)

RNA extraction and RT-qPCR of colon, hippocampus and prefrontal cortex were performed based on methods previously described [29]. Briefly, total RNA was extracted with TRIzol (Thermo Fisher Scientific, USA) from tissues of the colon, hippocampus and prefrontal cortex. RNA quantity was measured at 260 nm and purity was assessed by the optical density 260 nm/optical density 280 nm ratio. Then, 1 μg RNA for each sample was reverse-transcripted to cDNA using a high-capacity cDNA reverse transcription kit (Takara, Japan). qPCR was performed using the SYBR GREEN Master Mix (TaKaRa, Japan) and determined on a real-time PCR detection system (Bio-Rad, USA). Results were calculated using the comparative CT method (2−ΔΔCt) and expressed relative to the expression of the housekeeping gene GAPDH. Primer sequences were as follows: TNF-α-forward(F): 5′-CTTGTTGCCTCCTCTTTTGCTTA-3′, TNF-α-reverse(R): 5′-CTTTATTTCTCTCAATGACCCGTAG-3′; IL-1β-forward(F): 5′-TGGGAAACAACAGTGGTCAGG-3′, IL-1β-reverse(R): 5′-CTGCTCATTCACGAAAAGGGA-3′; IL-6-forward(F): 5′-TCACAGAAGGAGTGGCTAAGGACC-3′, IL-6-reverse(R): 5′-ACGCACTAGGTTTGCCGAGTAGAT-3′; β-GAPDH-forward(F): 5′-AGAAGGTGGTGAAGCAGGCATC-3′, β-GAPDH-reverse(R): 5′-CGAAGGTGGAAGAGTGGGAGTTG-3’.

Statistical analysis

All data are reported as mean ± standard error of the mean (SEM). Data analysis was performed using one-way analysis of variance (ANOVA), followed by Tukey post-hoc test. Statistical analyses were performed in SPSS 20.0. P < 0.05 was considered statistically significant.

Results

Short-term L. edodes derived β-glucan supplementation attenuated the gut microbiota dysbiosis induced by HF diet

Our previous studies have shown that chronic HF diet led to microbial dysbiosis with regards to diversity and composition [15, 16]. It is unknown if a short-term HF diet could alter microbiota and L. edodes derived β-glucan could prevent HF diet-induced microbiota shift. The profiles of gut microbiota after a short-term HF diet with or without L. edodes derived β-glucan supplementation for 7 days by 16S rRNA sequencing. Only a slight increase in mean proportion of Firmicutes, and decrease in mean proportion of Bacteroidetes were observed in short-term HF diet-fed mice compared to LC mice. However, the ratio of Firmicutes to Bacteroidetes were significantly elevated in the HF group (Fig. 1a–c). Nevertheless, L. edodes β-glucan supplementation prevented the alterations mentioned above (Fig. 1a–c). Meanwhile, the mean proportion of Proteobacteria and Actinobacteria was significantly decreased by the HF diet, while short-term L. edodes supplementation improved the abundance of Proteobacteria (P < 0.05, Fig. 1d, e). While there was no significant difference in bacterial diversity (in Shannon index) among the three groups (Fig. 1f).

Fig. 1
figure 1

Short-term L. edodes derived β-glucan supplementation attenuated the gut microbiota dysbiosis induced by HF diet. a The relative abundance of Firmicutes, b the relative abundance of Bacteroidetes, c the ratio of Firmicutes (FM) to Bacteroidetes (BO), d the relative abundance of Proteobacteria, e the relative abundance of Actinobacteria, f the Shannon index, g the linear discriminant analysis (LDA) effect size results on mice gut microbiomes, h the plasma LPS levels in the sera, i body weight, j energy intake. Data are presented as mean ± standard error of means (SEM). n = 6 per group. *P < 0.05, ***P < 0.001, vs lab chow diet group (LC); #P < 0.05, ## P < 0.01, ###P < 0.001, vs high-fat diet group (HF). HFL, L. edodes β-glucan supplementation in HF diet group

Full size image

Using a linear discriminant analysis (LDA) effect size (LEfSe) calculation, 24 abundant taxonomic classes with LDA score higher than 3.0 (Fig. 1g) were identified. In detail, bacteria belonging to order Lactobacillales, class Bacilli, family Enterococcaceae, family Erysipelotrichaceae, order Erysipelotrichales, class Erysipelotrichia, family Rnodobacteraceae, order Rhodobacterales, family Mycoplasmataceae, order Mycoplasmatales, family Family_Xlll, order Pasteurellales and family Pasteurellaceae were elevated significantly in HF mice compared to control. Furthermore, L. edodes β-glucan supplementation significantly increased the order Clostridiales, class Clostridia, family Lachnospiraceae and family Ruminococcaceae (Fig. 1g). Consistent with the altered microbiota, slightly elevated plasma levels of LPS were observed in HF diet-fed mice, which was reversed by the supplementation of L. edodes β-glucan (Fig. 1h). Together, these results indicated that short-term L. edodes β-glucan attenuated the gut microbiota dysbiosis induced by HF diet.

Furthermore, the short-term HF diet administration increased the energy intake, but did not increase the body weight (Fig. 1i, j). The short-term L. edodes β-glucan supplementation did not affect the body weight compared to control mice and HF mice (Fig. 1i). Moreover, the β-glucan supplementation increased energy intake compared to control, but not compared to HF mice (Fig. 1j).

Long-term L. edodes derived β-glucan supplementation prevented the gut microbiota dysbiosis induced by HF diet

In long-term HF diet-fed mice, a significant increase in the mean proportion of Firmicutes (Additional file 1: Fig. S1A, B) and Proteobacteria and a significant decline of Bacteroidetes were observed compared to LC mice (Additional file 1: Fig. S1D). Moreover, the ratio of Firmicutes to Bacteroidetes was significantly elevated in the HF group (Additional file 1: Fig. S1C). Importantly, L. edodes β-glucan supplementation prevented the alterations mentioned above, except for the mean proportion of Bacteroidetes (Additional file 1: Fig. S1A–D). In addition, L. edodes β-glucan supplementation significantly increased the mean proportion of Actinobacteria in HF diet-fed mice, although the HF diet did not obviously affect the phylum compared to the LC diet (Additional file 1: Fig. S1E). However, there was no significant difference in bacterial diversity (in Shannon index) among the three groups (Additional file 1: Fig. S1F), which was similar to the results in the short-term administration of L. edodes β-glucan. Taken together, these results indicated that long-term L. edodes β-glucan also prevented the gut microbiota dysbiosis induced by HF diet.

Long-term L. edodes derived β-glucan supplementation prevented HF diet-induced cognitive decline

Since that gut microbiota dysbiosis and obesity are strongly linked to cognitive decline [16], we further determined whether L. edodes β-glucan could prevent cognitive decline induced by chronic HF diet. In the temporal order memory test, chronic HF diet resulted in a decrease in recognition memory compared with the LC mice (P < 0.05, Fig. 2a). Compared with the LC group, the HF group exhibited a decreased discrimination index, suggesting that the recognition memory of HF mice was impaired. However, L. edodes β-glucan administration significantly increased the discrimination index, which even exceeded the LC mice (P < 0.001, Fig. 2a). Moreover, a similar protective effect of L. edodes β-glucan supplementation was observed in the novel object recognition test (P < 0.05, Fig. 2b). In addition, the alternation triplet of HF mice was lower than that of LC and L. edodes β-glucan fed mice in the Y-maze test (P < 0.05, Fig. 2c). All these behavior results implied that L. edodes β-glucan prevents HF diet-induced cognitive decline. Furthermore, the cumulative body weight gain and final body weight of HF mice were significantly higher than those of LC mice, and chronic L. edodes β-glucan significantly lowered body weight gain and final body weight in HF mice (P < 0.01, Additional file 2: Fig. S2A, B). However, there was no obvious change of cumulative energy intake in the mice fed by L. edodes β-glucan plus HF diet in comparison to HF mice (P < 0.05, Additional file 2: Fig. S2C). In line with the body weight change, the mass of liver, subcutaneous fat, epididymal fat and brown fat was significantly lower in HF mice following L. edodes β-glucan supplementation (all P < 0.05, Additional file 2: Fig. S2D, E). In addition, L. edodes β-glucan adminstration markedly improved glucose intolerance (P < 0.05, Additional file 2: Fig. S2F). Together, these results suggested L. edodes β-glucan prevented HF-induced obesity and cognitive decline.

Fig. 2
figure 2

Long-term L. edodes derived β-glucan supplementation prevented HF diet-induced cognitive decline. a Discrimination index in the temporal order memory test, b discrimination index in the novel object recognition test, c proportion of correct alternations in the Y-maze test. n = 10 per group. Data are presented as mean ± SEM. *P < 0.05, **P < 0.01, ***P < 0.001, vs lab chow diet group (LC); #P < 0.05, ##P < 0.01, vs high-fat diet group (HF). HFL, L. edodes β-glucan supplementation in HF diet group

Full size image

Long-term L. edodes derived β-glucan supplementation maintained colonic integrity and alleviated inflammation induced by HF diet

Gut microbiota dysbiosis is positively associated with the damage of the intestinal barrier and endotoxinemia [16]. Therefore the colonic mucus and epithelium tight junction proteins were examined in response to L. edodes β-glucan supplementation. With Alcian blue staining, we found that the mucosal thickness in the colon was decreased in HF diet-fed mice compared to the LC group, while L. edodes β-glucan supplementation increased colonic mucosal thickness (P < 0.001, Fig. 3a, b). Moreover, western blot results showed that the protein level of occludin in the colon of HF diet mice was significantly decreased, while L. edodes β-glucan supplementation upregulated the protein expression of occludin (P < 0.01, Fig. 3c, d), indicative of enhanced tight junctions of colonic epithelial tissues. Consistently, the level of serum LPS was significantly increased with a chronic HF diet, which was reduced with L. edodes β-glucan supplementation compared to the HF group (P < 0.05, Fig. 3e). Thus, these results suggested that chronic L. edodes β-glucan supplementation maintained colonic integrity in the context of the HF diet.

Fig. 3
figure 3

Long-term L. edodes derived β-glucan supplementation maintained colonic integrity and alleviated inflammation induced by HF diet. a Representative figure of alcian blue staining for colon, b quantification of colonic mucus layer thickness, c protein expression levels of occludin in the colon, d plasma LPS levels, e the representative image of immunohistochemical staining of colonic F4/80-positive cells, f quantification of colonic F4/80-positive cells, g mRNA expression of TNF-α, IL-6 and IL-1β in the colon. Data are presented as mean ± SEM. n = 3 per group. *P < 0.05, **P < 0.01, ***P < 0.001, vs lab chow diet group (LC); #P < 0.05, ##P < 0.01, ###P < 0.001, vs high-fat diet group (HF). HFL, L. edodes β-glucan supplementation in HF diet group

Full size image

The macrophage is one of the most abundant immune cells in the colon [30], which plays a vital role in intestinal immunity and homeostasis [31]. The immunohistochemical staining showed that compared with the LC group, the number of macrophage marker F4/80 positive cells in the HF group were significantly increased (P < 0.001, Fig. 3f, g); however, the number of F4/80-positive cells was markedly reduced by L. edodes β-glucan supplementation (P < 0.05, Fig. 3f, g), suggesting inhibition of macrophage activation. Consistent with the immunohistochemical staining results, RT-PCR results showed that the levels of proinflammatory cytokines IL-6, TNF-α and IL-1β were up-regulated in the colon of HF mice (P < 0.001, Fig. 3h), while L. edodes β-glucan inhibited the expression of these proinflammatory cytokines induced by HF diet (P < 0.01, Fig. 3h). Overall, these results suggested that the L. edodes derived β-glucan alleviated HF diet-induced colonic inflammation.

Long-term L. edodes derived β-glucan supplementation inhibited the microgliosis and neuroinflammation in the mice fed HF diet

It is reported that intestinal barrier impairment and endotoxinemia can mediate microglial activation and neuroinflammation through the gut-brain axis [16]. Moreover, the hippocampus and the cortex, regions implicated in cognitive processing, learning and memory, may be particularly vulnerable to inflammation in obesity [32, 33]. The present study further determined the effects of L. edodes on microgliosis and neuroinflammation induced by the HF diet in the hippocampus and prefrontal cortex (PFC). Using Iba1 as the marker of microglia, we observed that the HF diet increased microglia number in the hippocampal regions, including cornus ammonis (CA1), CA3 and dentate gyrus (DG), while L. edodes β-glucan significantly reduced microglial number (all P < 0.05, Fig. 4a, b). Moreover, the downregulated expression of proinflammatory cytokines (TNF-α, IL-6, IL-1β) was observed in the hippocampus after L. edodes β-glucan supplementation (all P < 0.05, Fig. 4c). In the PFC, L. edodes β-glucan could inhibit the proliferation of microglia (P < 0.01, Fig. 5b) and downregulate the expression of proinflammatory cytokines (TNF-α, IL-6, IL-1β) induced by the HF diet (all P < 0.05, Fig. 5c). These results indicated that L. edodes β-glucan inhibited the microgliosis and inflammation in the hippocampus and PFC of mice fed the HF diet.

Fig. 4
figure 4

Long-term L. edodes derived β-glucan supplementation inhibited the microgliosis and neuroinflammation in the hippocampus of mice fed HF diet. a The representative image of immunohistochemistry staining of Iba1 in the cornus ammonis (CA1), CA3 and dentate gyrus (DG) regions of hippocampus, b the statistical results of Iba1+ positive cells in mentioned regions. c mRNA expression of TNF-α, IL-6 and IL-1β in the hippocampus. Data are presented as mean ± SEM. n = 3 per group. *P < 0.05, **P < 0.01, ***P < 0.001, vs lab chow diet group (LC); #P < 0.05, ##P < 0.01, ###P < 0.001, vs high-fat diet group (HF). HFL, L. edodes β-glucan supplementation in HF diet group

Full size image
Fig. 5
figure 5

Long-term L. edodes derived β-glucan supplementation inhibited the microgliosis and neuroinflammation in the prefrontal cortex of mice fed HF diet. a The representative image of immunohistochemistry staining of Iba1 in PFC, b the statistical results of Iba1+ positive cells in PFC. (C) mRNA expression of TNF-α, IL-6, and IL-1β in the PFC. Data are presented as mean ± SEM. n = 3 per group. *P < 0.05, **P < 0.01, vs lab chow diet group (LC); #P < 0.05, ##P < 0.01, ### P < 0.001, vs high-fat diet group (HF). HFL, L. edodes β-glucan supplementation in HF diet group

Full size image

Long-term L. edodes derived β-glucan supplementation alleviated the synaptic impairment in the mice fed HF diet

Microglial activation and neuroinflammation are the leading risk factors for cognitive decline, which are involved in the pathogenesis of neurodegenerative diseases via altering synaptic ultrastructure and plasticity [7, 34]. This study examined if L. edodes altered synaptic ultrastructure and the expression of synapse-associated markers. Synaptic ultrastructure in the CA1 region of the hippocampus and PFC was analyzed using Transmission electron microscopy (TEM). In the CA1 region of the hippocampus, the decreased thickness of the postsynaptic densities (PSD), the broader of the synaptic cleft and reduced curvature of the synaptic interface were found in HF diet mice (all P < 0.05, Fig. 6a–d). Interestingly, L. edodes β-glucan administration prevented these pathogenic change induced by the HF diet, exhibiting a thicker PSD, narrower synaptic cleft, and higher curvature of the synaptic interface (all P < 0.05, Fig. 6a–d). Moreover, the protein levels of synapse plasticity markers, brain-derived neurotrophic factor (BDNF) and postsynaptic density-95 (PSD-95) were significantly inhibited by HF diet (P < 0.05, Fig. 6e); however, their expression levels were recovered after L. edodes β-glucan (P < 0.05, Fig. 6e). Furthermore, compared to the HF group, a similar trend has been gained in the PFC of mice after L. edodes β-glucan supplementation (Fig. 7). In summary, these results indicated that L. edodes β-glucan could improve synaptic morphology and plasticity in the hippocampus and PFC, thereby preventing cognitive decline induced by HF diet.

Fig. 6
figure 6

Long-term L. edodes derived β-glucan supplementation alleviated the synaptic impairment in the hippocampus of mice fed HF diet. a Representative electron micrograph of synaptic ultrastructure in the hippocampus cornus ammonis (CA1), CA3 and dentate gyrus (DG) regions, b statistical analysis of the thickness of PSD, the width of synaptic cleft (c), and curvature of the synaptic interface in the hippocampus (d), e protein expression levels of BDNF and PSD-95 in the hippocampus. Data are presented as mean ± SEM. n = 3 per group. *P < 0.05, **P < 0.01, vs lab chow diet group (LC); #P < 0.05, ##P < 0.01, vs high-fat diet group (HF). HFL, L. edodes β-glucan supplementation in HF diet group

Full size image
Fig. 7
figure 7

Long-term L. edodes derived β-glucan supplementation alleviated the synaptic impairment in the prefrontal cortex of mice fed HF diet. a Representative electron micrograph of synaptic ultrastructure in the prefrontal cortex (PFC) region, b statistical analysis of PSD thickness, c statistical analysis of the width of synaptic cleft, d statistical analysis of the curvature of synaptic interface in the PFC, e protein expression levels of BDNF and PSD-95 in PFC. Data are presented as mean ± SEM. n = 3 per group. *P < 0.05, vs lab chow diet group (LC); #P < 0.05, vs high-fat diet group (HF). HFL, L. edodes β-glucan supplementation in HF diet group

Full size image

Discussion

The present study, with an obese cognitive impairment mice model, demonstrated the beneficial effects of L. edodes β-glucan supplementation on the gut microbiota-brain axis and improvement of cognitive decline. We showed that short-term and long-term L. edodes β-glucan supplementation alleviated the gut microbial dysbiosis induced by the HF diet. Notably, long-term supplementation with L. edodes β-glucan significantly improved the cognitive impairment in HF diet-fed mice, which was supported by the inhibition of microgliosis, alleviation of neuroinflammation and improvement of synaptic ultrastructure. Furthermore, long-term L. edodes β-glucan supplementation significantly mitigated the impairment of colonic barrier and inflammation in HF diet-fed mice. Collectively, these data demonstrated that L. edodes β-glucan ameliorated the cognitive deficits induced by chronic HF diet, and these neuroprotective effects potentially occurred through the improvement of the colon-microbiota-brain axis. Previously, edible mushrooms have shown beneficial effects on cognition in a cross-sectional study [20]. Here we reported that the main ingredient of edible mushroom, L. edodes β-glucan, improved the gut microbiota-brain axis. Therefore, the beneficial effects of β-glucan may contribute to the ability of mushroom in the improvement of cognitive function, as described previously in the human study [20].

The gut microbiome has emerged as a major contributor to cognitive health, and it can be remodeled by dietary factors. Recently, our laboratory demonstrated that gut microbiota dysfunction negatively impacts the cognitive impairments induced by HF diet [15, 16, 35]. Nevertheless, only a few studies focused on the alternation of gut microbiota occur before the onset of body weight gain in this model [35]. In previous long-term studies for HF diet for 8–22 weeks, it is reported that the proportion of gut bacteria belong to phylum Bacteroidetes is decreased, while phylum Firmicutes is increased in rodents with an increased ratio of Firmicutes to Bacteroidetes [36]. The alternation of these indexes was also observed in the present study, in which the mice were fed by HF diet for 15 weeks. Moreover, the changes were reversed by the long-term supplementation of L. edodes β-glucan. Interestingly, in our short-term HF diet for 7 days, although there was a slight increase in the Firmicutes and decrease in the Bacteroidetes, the alteration of these bacteria did not a reach statically significant difference in the gut microbiota of mice. It suggests that microbiota alteration in the Bacteroidetes and Firmicutes is in progress along with the duration of HF diet feeding. However, in the present study, we found that the mean proportion of Proteobacteria and Actinobacteria at phylum was significantly decreased by the short-term HF diet, suggesting the composition of Proteobacteria and Actinobacteria altered early before the significant change in the Bacteroidetes and Firmicutes. In addition, in the long-term study of HF diet, the richness and diversity of gut microbiota in mice were altered [3], characterized by decreased Chao index and Shannon index. While in the present short-term study, HF diet feeding did significantly change the richness (Chao index) and diversity (Shannon index). This indicates that the shift in the composition of gut microbiota, especially in Proteobacteria and Actinobacteria, occurred before any changes in microbiome diversity and richness during HF diet feeding. Importantly, we found that supplementation of dietary L. edodes β-glucan prevented this shift in microbiota composition, as it significantly increased Bacteroides and decreased Firmicutes. Consistent with our findings, two previous studies have shown a similar capability of L. edodes β-glucan to alleviate the gut microbiome dysbiosis in aged mice and insulin deficient type 2 diabetic rats [18, 19]. In addition, it has been reported that microbiota belonging to the phylum Bacteroidetes is associated with cognition and neurodegenerative diseases [37]. For example, in a cross-section study, a lower abundance of Bacteroides at the genus is reported in the gut microbiota of dementia patients [38]. Interestingly, the consumption of mushrooms has been shown to reduce the risk of mild cognitive impairment in aged individuals [20]. This study found that the increased abundance of Bacteriodetes phylum following L. edodes β-glucan administration. Thus, it is rationally proposed that dietary L. edodes β-glucan in promoting the abundance of certain members of the bacterial community belongs to the Bacteroidetes phylum, contribute to ameliorate the cognitive impairments induced by HF diet.

Emerging research is revealing that gut microbiota has potent effects on gut permeability and endotoxemia [27]. The gut barrier consists of semi-permeable mucosal, as well as epithelial cell layers reinforced by tight junction proteins. This barrier serves to regulate nutrient and water entry and prevents the entry of harmful compounds into extra-luminal tissues. HF diet consumption impairs gut permeability, which, in turn, allows for the influx of adverse substances [39]. A compromised gut barrier makes the intestinal tract potentially vulnerable to the gram-negative bacteria-derived LPS, which upon excess entry into circulation, promotes endotoxemia and systemic inflammation [16, 40, 41]. According to previous studies, we found that HF diet intake dramatically increased intestinal inflammation and diminished intestinal barrier integrity, which is consistent with the increased level of LPS in the sera of mice. However, long-term L. edodes β-glucan supplementation increased colonic mucus thickness, upregulated colonic tight-junction protein occludin levels and lowered the LPS level in sera, indicating that L. Edodes alleviated the loss of intestinal barrier integrity induced by HF diet. It is reported that the outer membrane protein of Bacteroidetes can bind to β-glucan [42]. Moreover, the genome of Bacteroidetes encodes many β-glucan lyases and glycoside hydrolases, which are largely involved in the acquisition and metabolism of β-glucan [43]. Thus, it is possible that L. edodes β-glucan favoured the growth of the β-glucan-degrading Bacteroidetes and its next taxonomic levels observed in our study. In the present study, we found that at the phylum level, the short-term supplementation of L. edodes β-glucan for 7 days significantly increased the proportion of Bacteroidetes in mice fed with HF diet. Previously, in a chronic study, the effect of barley β-glucan supplementation for 5 weeks increased Bacteroidetes in gut microbiota in humans [44]. These results suggest that the changes in microbiota, such as Bacteroidetes by the short-term supplementation of β-glucan may maintain after long-term supplementation. In addition, Bacteroidetes has been reported to benefit their host mucus and gut barrier [10]. Therefore, L. edodes β-glucan might be fermented by Bacteroidetes, to provide an energy source for bacteria within the Bacteroidetes phylum. In accordance with this, the glycan production in mucus was significantly increased by L. edodes β-glucan supplementation, which thus prevented the epithelial damage induced by the HF diet. This, in turn, might relieve the translocation of bacterial LPS into the blood circulation.

The hippocampus and the cortex, regions implicated in cognitive processing, learning and memory, are particularly vulnerable to inflammation in obesity [32, 45]. It is reported that LPS from the intestinal tract was increased in the cortex and hippocampus of AD patients [46], which suggests that the increased gut permeability and hyperndotoxinemia could contribute to cognition decline. Our results showed that L. edodes β-glucan administration enhanced the intestinal barrier and resulted in a profound reduction in endotoxinemia, which may contribute to the improvements in cognition we observed by a comprehensive array of behavioral, learning and memory tests. Neuroinflammation is considered to be the link between gut dysbiosis to synaptic and cognitive decline, while it is also one of the key mechanisms underlying various neurodegenerative diseases [47]. LPS over-exposure by intraperitoneal injection has been reported to induce microglial activation and increased expression of proinflammatory cytokines in the brains of mice 48. Moreover, the gut microbiota directly stimulates the production of the proinflammatory cytokines IL-1β and TNF-α [49], which have been shown to impair hippocampal-dependent memories in rodents [50, 51]. In the present study, we found that a long-term HF diet upregulated TNF-α, IL-6 and IL-1β in the PFC and hippocampus, which were attenuated by long-term L. edodes β-glucan supplementation, indicative of an anti-neuroinflammatory effect of L. edodes β-glucan.

There is accumulating evidence demonstrates the microglia play a vital role in mediating the cognitive dysfunction in neurodegenerative dysfunctions [52]. Microglia, the resident immune cells of the central nervous system, maintain brain homeostasis and contribute to brain development. However, excessive microglial activation can damage the surrounding healthy neural tissue, and the factors secreted by the dead or dying neurons, in turn, exacerbate the chronic activation of microglia, causing progressive loss of neurons and then cognitive impairment [8, 52]. This study showed the HF diet promoted the accumulation of microglia in the PFC and hippocampus, which was inhibited by long-term L. edodes β-glucan supplementation. Synaptic structure and plasticity are closely correlated with learning and memory functions [34]. The dysregulation of synaptic formation and plasticity in the hippocampus has been implicated in patients with cognitive impairment and AD [53]. We herein showed the long-term HF diet disrupted the ultrastructural synaptic architecture in the PFC and hippocampus, which was characterized by decreased PSD thickness and broadened synaptic cleft observed by the TEM technique. Notably, long-term L. edodes β-glucan supplementation prevented the damage of ultrastructural synaptic architecture induced by the HF diet. Consistently, we also found that L. edodes β-glucan supplementation reversed HF diet-associated decreases in the molecular markers of synaptic plasticity, BDNF and PSD-95 in the PFC and hippocampus. Therefore, L. edodes β-glucan supplementation significantly improved the ultrastructure and increased synaptic protein expression, which thus supported the enhancement and maintenance in cognitive function despite chronic HF diet feeding following L. edodes β-glucan treatment.

Conclusion

In summary, the present study has demonstrated that dietary L. edodes β-glucan supplementation prevented cognitive impairment induced by the HF diet in mice, which might result from the improvement of the colon-brain axis. The finding provides evidence that by L. edodes β-glucan can be a novel nutritional treatment to prevent cognitive deficits induced by long-term intake of the western diet.

Availability of data and materials

All datasets generated for this study are included in the article additional materials.

References

  1. González-Muniesa P, Mártinez-González MA, Hu FB, Després JP, Matsuzawa Y, Loos RJF, Moreno LA, Bray GA, Martinez JA. Obesity. Nat Rev Dis Primers. 2017;3:17034.

    PubMed  Article  Google Scholar 

  2. Fruh SM. Obesity: risk factors, complications, and strategies for sustainable long-term weight management. J Am Assoc Nurse Pract. 2017;29:S3-s14.

    PubMed  PubMed Central  Article  Google Scholar 

  3. O’Brien PD, Hinder LM, Callaghan BC, Feldman EL. Neurological consequences of obesity. Lancet Neurol. 2017;16:465–77.

    PubMed  PubMed Central  Article  Google Scholar 

  4. Elias MF, Elias PK, Sullivan LM, Wolf PA, D’Agostino RB. Obesity, diabetes and cognitive deficit: The Framingham Heart Study. Neurobiol Aging. 2005;26(Suppl 1):11–6.

    PubMed  Article  CAS  Google Scholar 

  5. Sabia S, Kivimaki M, Shipley MJ, Marmot MG, Singh-Manoux A. Body mass index over the adult life course and cognition in late midlife: the Whitehall II Cohort Study. Am J Clin Nutr. 2009;89:601–7.

    CAS  PubMed  Article  Google Scholar 

  6. Enzinger C, Fazekas F, Matthews PM, Ropele S, Schmidt H, Smith S, Schmidt R. Risk factors for progression of brain atrophy in aging: six-year follow-up of normal subjects. Neurology. 2005;64:1704–11.

    CAS  PubMed  Article  Google Scholar 

  7. Subhramanyam CS, Wang C, Hu Q, Dheen ST. Microglia-mediated neuroinflammation in neurodegenerative diseases. Semin Cell Dev Biol. 2019;94:112–20.

    CAS  PubMed  Article  Google Scholar 

  8. Rajendran L, Paolicelli RC. Microglia-mediated synapse loss in Alzheimer’s disease. J Neurosci. 2018;38:2911–9.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  9. Xie J, Wang H, Lin T, Bi B. Microglia-Synapse Pathways: Promising Therapeutic Strategy for Alzheimer’s Disease. Biomed Res Int. 2017;2017:2986460.

    PubMed  PubMed Central  Google Scholar 

  10. Hsiao EY, McBride SW, Hsien S, Sharon G, Hyde ER, McCue T, Codelli JA, Chow J, Reisman SE, Petrosino JF, et al. Microbiota modulate behavioral and physiological abnormalities associated with neurodevelopmental disorders. Cell. 2013;155:1451–63.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  11. Erny D, Hrabě de Angelis AL, Jaitin D, Wieghofer P, Staszewski O, David E, Keren-Shaul H, Mahlakoiv T, Jakobshagen K, Buch T, et al. Host microbiota constantly control maturation and function of microglia in the CNS. Nat Neurosci. 2015;18:965–77.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  12. Sharon G, Sampson TR, Geschwind DH, Mazmanian SK. The Central Nervous System and the Gut Microbiome. Cell. 2016;167:915–32.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  13. Brett BE, de Weerth C. The microbiota-gut-brain axis: A promising avenue to foster healthy developmental outcomes. Dev Psychobiol. 2019;61:772–82.

    PubMed  PubMed Central  Article  Google Scholar 

  14. Sun J, Liu S, Ling Z, Wang F, Ling Y, Gong T, Fang N, Ye S, Si J, Liu J. Fructooligosaccharides ameliorating cognitive deficits and neurodegeneration in APP/PS1 transgenic mice through modulating gut microbiota. J Agric Food Chem. 2019;67:3006–17.

    CAS  PubMed  Article  Google Scholar 

  15. Zhang P, Yu Y, Qin Y, Zhou Y, Tang R, Wang Q, Li X, Wang H, Weston-Green K, Huang XF, Zheng K. Alterations to the microbiota-colon-brain axis in high-fat-diet-induced obese mice compared to diet-resistant mice. J Nutr Biochem. 2019;65:54–65.

    CAS  PubMed  Article  Google Scholar 

  16. Shi H, Wang Q, Zheng M, Hao S, Lum JS, Chen X, Huang XF, Yu Y, Zheng K. Supplement of microbiota-accessible carbohydrates prevents neuroinflammation and cognitive decline by improving the gut microbiota-brain axis in diet-induced obese mice. J Neuroinflamm. 2020;17:77.

    CAS  Article  Google Scholar 

  17. Bisen PS, Baghel RK, Sanodiya BS, Thakur GS, Prasad GB. Lentinus edodes: a macrofungus with pharmacological activities. Curr Med Chem. 2010;17:2419–30.

    CAS  PubMed  Article  Google Scholar 

  18. Xu X, Yang J, Ning Z, Zhang X. Lentinula edodes-derived polysaccharide rejuvenates mice in terms of immune responses and gut microbiota. Food Funct. 2015;6:2653–63.

    CAS  PubMed  Article  Google Scholar 

  19. Yang HJ, Kim MJ, Kwon DY, Kim DS, Zhang T, Ha C, Park S. Combination of aronia, red ginseng, shiitake mushroom and nattokinase potentiated insulin secretion and reduced insulin resistance with improving gut microbiome dysbiosis in insulin deficient type 2 diabetic rats. Nutrients. 2018;10:54.

    Article  CAS  Google Scholar 

  20. Feng L, Cheah IK, Ng MM, Li J, Chan SM, Lim SL, Mahendran R, Kua EH, Halliwell B. The association between mushroom consumption and mild cognitive impairment: a community-based Cross-Sectional Study in Singapore. J Alzheimers Dis. 2019;68:197–203.

    CAS  PubMed  Article  Google Scholar 

  21. Lynch SV, Pedersen O. The human intestinal microbiome in health and disease. N Engl J Med. 2016;375:2369–79.

    CAS  PubMed  Article  Google Scholar 

  22. de Sales GJ, Marcelino BAR, Konig IFM, Orlando TM, Varaschin MS, Pereira LJ. Therapeutic effects of different doses of prebiotic (isolated from Saccharomyces cerevisiae) in comparison to n-3 supplement on glycemic control, lipid profiles and immunological response in diabetic rats. Diabetol Metab Syndr. 2020;12:69.

    Article  CAS  Google Scholar 

  23. Babícek K, Cechová I, Simon RR, Harwood M, Cox DJ. Toxicological assessment of a particulate yeast (1,3/1,6)-beta-d-glucan in rats. Food Chem Toxicol. 2007;45:1719–30.

    PubMed  Article  CAS  Google Scholar 

  24. Uribe-Mariño A, Gassen NC, Wiesbeck MF, Balsevich G, Santarelli S, Solfrank B, Dournes C, Fries GR, Masana M, Labermeier C, et al. Prefrontal cortex corticotropin-releasing factor receptor 1 conveys acute stress-induced executive dysfunction. Biol Psychiatry. 2016;80:743–53.

    PubMed  Article  CAS  Google Scholar 

  25. Jin G, Bai D, Yin S, Yang Z, Zou D, Zhang Z, Li X, Sun Y, Zhu Q. Silibinin rescues learning and memory deficits by attenuating microglia activation and preventing neuroinflammatory reactions in SAMP8 mice. Neurosci Lett. 2016;629:256–61.

    CAS  PubMed  Article  Google Scholar 

  26. Wu J, Dong L, Zhang M, Jia M, Zhang G, Qiu L, Ji M, Yang J. Class I histone deacetylase inhibitor valproic acid reverses cognitive deficits in a mouse model of septic encephalopathy. Neurochem Res. 2013;38:2440–9.

    CAS  PubMed  Article  Google Scholar 

  27. Desai MS, Seekatz AM, Koropatkin NM, Kamada N, Hickey CA, Wolter M, Pudlo NA, Kitamoto S, Terrapon N, Muller A, et al. A dietary fiber-deprived gut microbiota degrades the colonic mucus barrier and enhances pathogen susceptibility. Cell. 2016;167(1339–1353):e1321.

    Google Scholar 

  28. Xu N, Fan W, Zhou X, Liu Y, Ma P, Qi S, Gu B. Probiotics decrease depressive behaviors induced by constipation via activating the AKT signaling pathway. Metab Brain Dis. 2018;33:1625–33.

    CAS  PubMed  Article  Google Scholar 

  29. Mei PJ, Bai J, Miao FA, Li ZL, Chen C, Zheng JN, Fan YC. Relationship between expression of XRCC1 and tumor proliferation, migration, invasion, and angiogenesis in glioma. Invest New Drugs. 2019;37:646–57.

    CAS  PubMed  Article  Google Scholar 

  30. Zigmond E, Varol C, Farache J, Elmaliah E, Satpathy AT, Friedlander G, Mack M, Shpigel N, Boneca IG, Murphy KM, et al. Ly6C hi monocytes in the inflamed colon give rise to proinflammatory effector cells and migratory antigen-presenting cells. Immunity. 2012;37:1076–90.

    CAS  PubMed  Article  Google Scholar 

  31. Bader JE, Enos RT, Velázquez KT, Carson MS, Nagarkatti M, Nagarkatti PS, Chatzistamou I, Davis JM, Carson JA, Robinson CM, Murphy EA. Macrophage depletion using clodronate liposomes decreases tumorigenesis and alters gut microbiota in the AOM/DSS mouse model of colon cancer. Am J Physiol Gastrointest Liver Physiol. 2018;314:G22-g31.

    PubMed  Article  CAS  Google Scholar 

  32. Jeon BT, Jeong EA, Shin HJ, Lee Y, Lee DH, Kim HJ, Kang SS, Cho GJ, Choi WS, Roh GS. Resveratrol attenuates obesity-associated peripheral and central inflammation and improves memory deficit in mice fed a high-fat diet. Diabetes. 2012;61:1444–54.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  33. Dinel AL, André C, Aubert A, Ferreira G, Layé S, Castanon N. Lipopolysaccharide-induced brain activation of the indoleamine 2,3-dioxygenase and depressive-like behavior are impaired in a mouse model of metabolic syndrome. Psychoneuroendocrinology. 2014;40:48–59.

    CAS  PubMed  Article  Google Scholar 

  34. Bocarsly ME, Fasolino M, Kane GA, LaMarca EA, Kirschen GW, Karatsoreos IN, McEwen BS, Gould E. Obesity diminishes synaptic markers, alters microglial morphology, and impairs cognitive function. Proc Natl Acad Sci USA. 2015;112:15731–6.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  35. Yang X, Zheng M, Hao S, Shi H, Lin D, Chen X, Becvarovski A, Pan W, Zhang P, Hu M, et al. Curdlan prevents the cognitive deficits induced by a high-fat diet in mice via the gut-brain axis. Front Neurosci. 2020;14:384.

    PubMed  PubMed Central  Article  Google Scholar 

  36. Turnbaugh PJ, Bäckhed F, Fulton L, Gordon JI. Diet-induced obesity is linked to marked but reversible alterations in the mouse distal gut microbiome. Cell Host Microbe. 2008;3:213–23.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  37. Carlson AL, Xia K, Azcarate-Peril MA, Goldman BD, Ahn M, Styner MA, Thompson AL, Geng X, Gilmore JH, Knickmeyer RC. Infant gut microbiome associated with cognitive development. Biol Psychiatry. 2018;83:148–59.

    PubMed  Article  Google Scholar 

  38. Saji N, Niida S, Murotani K, Hisada T, Tsuduki T, Sugimoto T, Kimura A, Toba K, Sakurai T. Analysis of the relationship between the gut microbiome and dementia: a cross-sectional study conducted in Japan. Sci Rep. 2019;9:1008.

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  39. Slyepchenko A, Maes M, Machado-Vieira R, Anderson G, Solmi M, Sanz Y, Berk M, Köhler CA, Carvalho AF. Intestinal dysbiosis, gut hyperpermeability and bacterial translocation: missing links between depression, obesity and type 2 diabetes. Curr Pharm Des. 2016;22:6087–106.

    CAS  PubMed  Article  Google Scholar 

  40. Cani PD, Amar J, Iglesias MA, Poggi M, Knauf C, Bastelica D, Neyrinck AM, Fava F, Tuohy KM, Chabo C, et al. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes. 2007;56:1761–72.

    CAS  PubMed  Article  Google Scholar 

  41. Cani PD, Bibiloni R, Knauf C, Waget A, Neyrinck AM, Delzenne NM, Burcelin R. Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes. 2008;57:1470–81.

    CAS  PubMed  Article  Google Scholar 

  42. Tuson HH, Foley MH, Koropatkin NM, Biteen JS. The starch utilization system assembles around stationary starch-binding proteins. Biophys J. 2018;115:242–50.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  43. Thomas F, Hehemann JH, Rebuffet E, Czjzek M, Michel G. Environmental and gut bacteroidetes: the food connection. Front Microbiol. 2011;2:93.

    PubMed  PubMed Central  Article  Google Scholar 

  44. Wang Y, Ames NP, Tun HM, Tosh SM, Jones PJ, Khafipour E. High molecular weight barley β-glucan alters gut microbiota toward reduced cardiovascular disease risk. Front Microbiol. 2016;7:129.

    PubMed  PubMed Central  Google Scholar 

  45. Pepping JK, Freeman LR, Gupta S, Keller JN, Bruce-Keller AJ. NOX2 deficiency attenuates markers of adiposopathy and brain injury induced by high-fat diet. Am J Physiol Endocrinol Metab. 2013;304:E392-404.

    CAS  PubMed  Article  Google Scholar 

  46. Cattaneo A, Cattane N, Galluzzi S, Provasi S, Lopizzo N, Festari C, Ferrari C, Guerra UP, Paghera B, Muscio C, et al. Association of brain amyloidosis with pro-inflammatory gut bacterial taxa and peripheral inflammation markers in cognitively impaired elderly. Neurobiol Aging. 2017;49:60–8.

    CAS  PubMed  Article  Google Scholar 

  47. Lin L, Zheng LJ, Zhang LJ. Neuroinflammation, gut microbiome, and Alzheimer’s disease. Mol Neurobiol. 2018;55:8243–50.

    CAS  PubMed  Article  Google Scholar 

  48. Chen M, Chang YY, Huang S, Xiao LH, Zhou W, Zhang LY, Li C, Zhou RP, Tang J, Lin L, et al. Aromatic-turmerone attenuates LPS-induced neuroinflammation and consequent memory impairment by targeting TLR4-dependent signaling pathway. Mol Nutr Food Res. 2018;62:64.

    Google Scholar 

  49. Heumann D, Barras C, Severin A, Glauser MP, Tomasz A. Gram-positive cell walls stimulate synthesis of tumor necrosis factor alpha and interleukin-6 by human monocytes. Infect Immun. 1994;62:2715–21.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  50. Goshen I, Kreisel T, Ounallah-Saad H, Renbaum P, Zalzstein Y, Ben-Hur T, Levy-Lahad E, Yirmiya R. A dual role for interleukin-1 in hippocampal-dependent memory processes. Psychoneuroendocrinology. 2007;32:1106–15.

    CAS  PubMed  Article  Google Scholar 

  51. Hein AM, Stasko MR, Matousek SB, Scott-McKean JJ, Maier SF, Olschowka JA, Costa AC, O’Banion MK. Sustained hippocampal IL-1beta overexpression impairs contextual and spatial memory in transgenic mice. Brain Behav Immun. 2010;24:243–53.

    CAS  PubMed  Article  Google Scholar 

  52. Hong S, Beja-Glasser VF, Nfonoyim BM, Frouin A, Li S, Ramakrishnan S, Merry KM, Shi Q, Rosenthal A, Barres BA, et al. Complement and microglia mediate early synapse loss in Alzheimer mouse models. Science. 2016;352:712–6.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  53. Whitfield DR, Vallortigara J, Alghamdi A, Howlett D, Hortobágyi T, Johnson M, Attems J, Newhouse S, Ballard C, Thomas AJ, et al. Assessment of ZnT3 and PSD95 protein levels in Lewy body dementias and Alzheimer’s disease: association with cognitive impairment. Neurobiol Aging. 2014;35:2836–44.

    CAS  PubMed  Article  Google Scholar 

Download references

Acknowledgements

Not applicable.

Funding

This work was supported in part by the National Natural Science Foundation of China (Nos. 81870854, 82071184 and 81871670), the Jiangsu Specially Appointed Professors Program, the Natural Science Foundation of Jiangsu Province (No. BK20201459), the Natural Science Foundation of the Jiangsu Higher Education Institutions of China (No. 19KJA560003), the Starting Foundation for Talents of Xuzhou Medical University (No. D2018003), the Postgraduate Research & Practice Innovation Program of Jiangsu Province (Nos. KYCX20_2445, KYCX20_2467).

Author information

Author notes

  1. Wei Pan, Pengfei Jiang and Jinxiu Zhao contributed equally to this work

Authors and Affiliations

  1. Jiangsu Key Laboratory of Immunity and Metabolism, Department of Pathogen Biology and Immunology, Xuzhou Medical University, Xuzhou, 221004, Jiangsu, China

    Wei Pan, Pengfei Jiang, Jinxiu Zhao, Hongli Shi, Peng Zhang, Xiaoying Yang, Minmin Hu, Hui Hua, Xing Ge & Yinghua Yu

  2. Electron Microscope Unit, Mark Wainwright Analytical Centre, The University of New South Wales, Sydney, NSW, 2052, Australia

    Joanna Biazik

  3. Illawarra Health and Medical Research Institute (IHMRI), School of Medicine, University of Wollongong, Wollongong, NSW, 2522, Australia

    Xu-Feng Huang

Authors
  1. Wei Pan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Pengfei Jiang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jinxiu Zhao
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Hongli Shi
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Peng Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Xiaoying Yang
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Joanna Biazik
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Minmin Hu
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Hui Hua
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Xing Ge
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Xu-Feng Huang
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Yinghua Yu
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

WP, PZ, MH, XY, XH and YY designed the research study. WP, PJ, JZ, HS and JB performed the research. WP, YY, HH and XG analyzed the data. WP, PJ and JZ wrote the manuscript. XH and YY reviewed the manuscript. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Yinghua Yu.

Ethics declarations

Ethics approval and consent to participate

All animal care and experiments were carried out in strict accordance with the recommendations of the Guide for the Care and Use of Laboratory Animals of the Ministry of Health (China), and approved by the Ethics Committee of Xuzhou Medical University (Xuzhou, China, SCXK (Su) 2015-0009).

Consent to publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Additional file 1: Figure S1.

Long-term L. edodes derived β-glucan supplementation prevented the gut microbiota dysbiosis induced by HF diet. (A) the relative abundance of Firmicutes, (B) the relative abundance of Bacteroidetes, (C) the ratio of Firmicutes (FM) to Bacteroidetes (BO), (D) the relative abundance of Proteobacteria, (E) the relative abundance of Actinobacteria, (F) the Shannon index. Data are presented as mean ± standard error of means (SEM). n=5-6 per group. **P<0.05, ***P<0.001, vs lab chow diet group (LC); #P<0.05, ###P<0.001, vs high-fat diet group (HF). HFL, L. edodes β-glucan supplementation in HF diet group.

Additional file 2: Figure S2.

Long-term L. edodes derived β-glucan supplementation prevented HF diet-induced obesity in mice. (A) cumulative body weight gain, (B) cumulative energy intake, (C) final body weight, (D) liver mass, (E) the mass of subcutaneous, epididymal and brown fats, (F) blood glucose levels during glucose tolerance test (GTT), (G) area under the curve for GTT. Data are presented as mean ± SEM. n=10 per group. ** P<0.01, ***P<0.001, vs lab chow diet group (LC); #P<0.05, ##P<0.01, ###P<0.001, vs high-fat diet group (HF). HFL, L. edodes β-glucan supplementation in HF diet group.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Pan, W., Jiang, P., Zhao, J. et al. β-Glucan from Lentinula edodes prevents cognitive impairments in high-fat diet-induced obese mice: involvement of colon-brain axis. J Transl Med 19, 54 (2021). https://doi.org/10.1186/s12967-021-02724-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12967-021-02724-6

Keywords

  • Lentinula edodes
  • β-Glucan
  • Cognition
  • Microbiota
  • Gut-brain axis
  • High fat diet
  • Obesity